Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)
Clinical trial NCT00254982 · COMPLETED
Trial details
- NCT number
- NCT00254982
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2006-09-01
- Enrollment
- 593
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.